MetaCap

Neumora Therapeutics (NMRA) vs Pelthos Therapeutics (PTHS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Pelthos Therapeutics (PTHS) has outperformed Neumora Therapeutics (NMRA) over the past year, losing 24.5% versus a loss of 74.8%. Neumora Therapeutics is the larger company by market cap ($88.1 million vs $81.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NMRA-74.82%PTHS-24.47%
+101%+9%-83%
Oct 7, 20251 yearOct 7, 2026
NMRA-97.63%PTHS-56.27%
+5%-49%-103%
Feb 12, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NMRA versus PTHS key metrics
MetricNMRAPTHS
Share price$0.4689$21.16
Market cap$88.10M$81.01M
1-day change+0.13%+0.81%
YTD return-73.84%-32.29%
1-year return-74.82%-24.47%
EPS (TTM)$-1.23$-27.53
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.65$37.50
52-week low$0.451$18.19
Distance from 52-week high-87.15%-43.57%
Average volume1.18M59.15K
Shares outstanding187.90M3.83M
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PTHS has outperformed NMRA by 50.4 percentage points over the past year.

NMRA vs PTHS FAQ

Which is bigger, Neumora Therapeutics or Pelthos Therapeutics?

Neumora Therapeutics (NMRA) is larger, with a market capitalization of $88.10M compared with $81.01M for Pelthos Therapeutics (PTHS).

Which stock has performed better over the past year, NMRA or PTHS?

PTHS returned -24.47% over the past 12 months, compared with -74.82% for NMRA (price return, excluding dividends). Past performance does not predict future results.

Are Neumora Therapeutics and Pelthos Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons